Buy MOUNJARO 12.5 mg/.5mL tirzepatide

MOUNJARO 12.5 mg/.5mL is a subcutaneous injection solution containing tirzepatide. This medication is used to manage certain health conditions. Learn more about its uses and effects.

Strength

12.5 mg/.5mL

Pack Size

4 SYRINGE in 1 CARTON (0002-1460-80) / .5 mL in 1 SYRINGE (0002-1460-01)

Manufacturer / TM Owner

Eli Lilly and Company

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

MOUNJARO 12.5 mg/.5mL is primarily used for managing specific health conditions related to metabolic regulation. Tirzepatide, the active ingredient, is often prescribed to support weight management and improve glycemic control. People often ask, 'What is MOUNJARO used for?' and the answer typically involves its role in aiding weight loss and controlling blood sugar levels.

Side Effects

Common effects of MOUNJARO 12.5 mg/.5mL may include gastrointestinal symptoms such as nausea, diarrhea, and constipation. Some users also report fatigue and injection site reactions. These effects can vary widely among individuals.

Precautions & Warnings

MOUNJARO 12.5 mg/.5mL should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Always store the medication as directed to maintain its efficacy.

Avoid Interactions

MOUNJARO 12.5 mg/.5mL may interact with other medications, including those that affect blood sugar levels or digestion. It is advisable to consult a healthcare provider before combining it with other treatments. Alcohol and certain foods may also influence its effects.

References

Frequently Asked Questions

MOUNJARO is used to manage certain health conditions related to metabolic regulation, including weight management and glycemic control.

MOUNJARO is administered via subcutaneous injection. Follow the instructions provided by your healthcare professional for proper use.

Common side effects may include nausea, diarrhea, constipation, fatigue, and injection site reactions.

MOUNJARO may interact with other medications. Consult a healthcare provider before combining it with other treatments.

Store MOUNJARO as directed by the manufacturer, typically in a cool, dry place away from direct sunlight.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.